Literature DB >> 7407414

A new glucose-6-phosphate dehydrogenase deficient variant in a patient with Chediak-Higashi syndrome.

J T Prchal, W M Crist, A Malluh, A Vitek, W N Tauxe, A J Carroll.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7407414

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

1.  Disparate effect of beige mutation on cytotoxic function between natural killer and natural killer T cells.

Authors:  M Bannai; H Oya; T Kawamura; T Naito; T Shimizu; H Kawamura; C Miyaji; H Watanabe; K Hatakeyama; T Abo
Journal:  Immunology       Date:  2000-06       Impact factor: 7.397

2.  The NT 1311 polymorphism of G6PD: G6PD Mediterranean mutation may have originated independently in Europe and Asia.

Authors:  E Beutler; W Kuhl
Journal:  Am J Hum Genet       Date:  1990-12       Impact factor: 11.025

3.  Molecular heterogeneity underlying the G6PD Mediterranean phenotype.

Authors:  C M Corcoran; V Calabrò; G Tamagnini; M Town; B Haidar; T J Vulliamy; P J Mason; L Luzzatto
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

4.  Somatic-cell selection is a major determinant of the blood-cell phenotype in heterozygotes for glucose-6-phosphate dehydrogenase mutations causing severe enzyme deficiency.

Authors:  S Filosa; N Giacometti; C Wangwei; D De Mattia; D Pagnini; F Alfinito; F Schettini; L Luzzatto; G Martini
Journal:  Am J Hum Genet       Date:  1996-10       Impact factor: 11.025

5.  G6PD Cagliari: a new low activity glucose 6-phosphate dehydrogenase variant characterized by enhanced intracellular lability.

Authors:  A Morelli; U Benatti; L Guida; A De Flora
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

6.  Natural killer (HNK-1+) cells in Chediak-Higashi patients are present in normal numbers but are abnormal in function and morphology.

Authors:  T Abo; J C Roder; W Abo; M D Cooper; C M Balch
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.